-
NEWS: Policy interventions could reduce chronic liver disease and liver cancer in Europe by up to 7% by 2030
Europe has the largest burden of diagnosed liver disease globally with almost 30 million people in the European Union alone estimated to be living with a chronic liver condition. Liver cirrhosis accounts for 1.8% of all deaths reported in Europe (170,000 deaths annually) with a 100% increase in cirrhosis deaths observed across the Eastern European […]
-
NEWS: The Covid Hangover report launch
Our latest modelling project, undertaken for the Institute of Alcohol Studies, looks at how pandemic drinking patterns could impact alcohol-related disease and death.
-
NEWS: Making Conversations Count for All – Benefits of improving delivery of smoking cessation interventions for different socioeconomic groups
Today, Cancer Research UK has published a new report ‘Making Conversations Count for All: Benefits of improving delivery of smoking cessation interventions for different socioeconomic groups’ which includes modelling conducted by HealthLumen. This builds on the previous 2020 report, which aimed to estimate the burden of active smoking related disease in the UK and quantify the health and economic […]
-
Why we must work toward a recognised international standard in evaluation of upstream interventions
New blog published this week by Evidence & Policy co-authored by our COO and Co-Founder Laura Webber. The blog builds off research by Laura and collaborators at Lancaster University and the University of York on the health impacts universal basic income (UBI) could have. The role of UBI has come to the fore during the […]
-
NEWS: Making Conversations Count – The health and economic benefits of improving smoking cessation support in the UK
Today, Cancer Research UK has published a new report Making Conversations Work: The health and economic benefits of improving smoking cessation support in UK general practice which includes modelling conducted by HealthLumen. The report found that by 2039 improved delivery of stop smoking support in general practice in the UK could prevent: > 400,000 cases of smoking-related […]
-
NEWS: Estimating the burden of CKD in the UK
This week HealthLumen in partnership with AstraZeneca presented new work on the burden of chronic kidney disease (CKD) in the UK at the ERA-EDTA 2020 Congress. The study aims to compare and validate two different approaches to estimating the burden of CKD in the UK, and to estimate how this is predicted to change by […]
-
NEWS: Long-term health impacts of changing air pollution exposure in London
Today, the Mayor of London published a HealthLumen report commissioned by Transport for London and the Greater London Authority modelling the long-term health impacts of changing exposure to NO2 and PM2.5 in London. The report reveals that by 2050 the impact of current air quality policies, including the London Environment Strategy are predicted to result […]
-
NEWS: The Health of the Nation – A Strategy for Healthier Longer Lives
Yesterday saw the launch of the National Strategy to meet the government’s stated mission of “five extra healthy years by 2035”. The key challenge this initiative aims to address is that, whilst we are all living longer, too many of these years are just extra years of bad health. There are also continued, significant health […]